1
Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients
Condition(s):HIV; Zidovudine Adverse ReactionLast Updated:February 28, 2012Unknown status
Zidovudine: 573 Clinical Trials, Page 1 of 58
Hide Studies Not Open or Pending
2
Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada
Condition(s):HIV-1Last Updated:August 17, 2015Completed
3
Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions
Condition(s):HealthyLast Updated:October 24, 2008Completed
4
Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions
Condition(s):HealthyLast Updated:October 24, 2008Completed
5
Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)
Condition(s):HIV InfectionsLast Updated:March 16, 2012Completed
6
The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
Condition(s):HIV InfectionsLast Updated:March 16, 2012Completed
7
Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers
Condition(s):HealthyLast Updated:June 16, 2010Completed
8
Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal
Condition(s):HIV InfectionsLast Updated:September 6, 2013Completed
9
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
Condition(s):HIV InfectionsLast Updated:March 16, 2012Completed
10
The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
Condition(s):HIV InfectionsLast Updated:March 16, 2012Completed